Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Combined serological, genetic, and inflammatory markers differentiate non-IBD, Crohn's disease, and ulcerative colitis patients.

Inflammatory bowel diseases - 1 May 2013

Plevy Scott, Silverberg Mark S, Lockton Steve, Stockfisch Tom, Croner Lisa, Stachelski Jordan, Brown Michelle, Triggs Cheryl, Chuang Emil, Princen Fred, Singh Sharat

Abstract excerpt

BACKGROUND: Previous studies have demonstrated that serological markers can assist in diagnosing inflammatory bowel disease (IBD). In this study, we aim to build a diagnostic tool incorporating serological markers, genetic variants, and markers of inflammation into a computational algorithm to examine patterns of combinations of markers to (1) identify patients with IBD and (2) differentiate patients with Crohn's...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Algorithms
Share to Biomarkers

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Colitis, Ulcerative

Share to Crohn Disease

Share to Cross-Sectional Studies

Share to Follow-Up Studies

Share to Genetic Markers

Share to Inflammation

Source

Open in PubMed Open full text

Identifiers

PMID: 23518807
DOI: 10.1097/MIB.0b013e318280b19e
PMCID: PMC3792797

Genes

CRP
ECM1
STAT3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Combined serological, genetic, and inflammatory markers differentiate non-IBD, Crohn's disease, and ulcerative colitis patients.PMID 23518807Read ↗

Integrative biomarker discovery and immune profiling for ulcerative colitis: a multi-methodological approachSemantic proximity Read ↗

Molecular diagnosis and classification of inflammatory bowel disease.Semantic proximity Read ↗

Molecular Analysis of Inflammatory Bowel Disease: Clinically Useful Tools for Diagnosis, Response Prediction, and Monitoring of Targeted Therapy.Semantic proximity Read ↗

Deciphering Diagnostic Biomarkers and Immune Infiltration Characteristics in Ulcerative Colitis and Inflammatory Bowel Disease Through Genetic ProfilingSemantic proximity Read ↗

Development of a 32-gene signature using machine learning for accurate prediction of inflammatory bowel diseaseSemantic proximity Read ↗

[Diagnostic value of different serological markers and correlation analysis with disease phenotype in inflammatory bowel disease].Semantic proximity Read ↗

Identification of diagnostic biomarks and immune cell infiltration in ulcerative colitisSemantic proximity Read ↗

Predictors of intestinal inflammation in asymptomatic first-degree relatives of patients with Crohn’s diseaseSemantic proximity Read ↗

Identification of four potential hematologic biomarkers for the diagnosis of Crohn's DiseaseSemantic proximity Read ↗

The use of prognostic factors in inflammatory bowel diseases.Semantic proximity Read ↗

An integrated machine learning framework for developing and validating diagnostic models and drug predictions based on ulcerative colitis genesSemantic proximity Read ↗

A blood-based prognostic biomarker in inflammatory bowel diseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.